Vivacitas Oncology Inc is a clinical stage biopharmaceutical company focused on tough to treat cancers that are resistant to current treatment modalities. It originated in 2016 with the vision of Dr. Joseph Rubinfeld (co-founder of Amgen) and the intent to improve on well-known chemotherapies with demonstrated effect, but which may have issues with potency, toxicity, stability, or other characteristics that limit their use.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):